Header Logo

Connection

MICHAEL TAYLOR to Young Adult

Back to Details
This is a "connection" page, showing publications MICHAEL TAYLOR has written about Young Adult.
MICHAEL TAYLOR
Connection Strength
0.562
Young Adult
  1. Posterior fossa ependymoma: current insights. Childs Nerv Syst. 2015 Oct; 31(10):1699-706.
    View in: PubMed
    Score: 0.044
  2. [Molecular subgrouping and characterization analysis of medulloblastomas in a cohort of Japanese patients]. No Shinkei Geka. 2015 Feb; 43(2):117-25.
    View in: PubMed
    Score: 0.042
  3. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol. 2012 Apr; 123(4):615-26.
    View in: PubMed
    Score: 0.033
  4. Co-occurrence of congenital anomalies and childhood brain tumors in 22 million live births. Neuro Oncol. 2025 Sep 08; 27(7):1910-1922.
    View in: PubMed
    Score: 0.022
  5. Postoperative cerebellar mutism syndrome is an acquired autism-like network disturbance. Neuro Oncol. 2024 05 03; 26(5):950-964.
    View in: PubMed
    Score: 0.020
  6. Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. Nat Med. 2022 01; 28(1):125-135.
    View in: PubMed
    Score: 0.017
  7. Subgroup and subtype-specific outcomes in adult medulloblastoma. Acta Neuropathol. 2021 11; 142(5):859-871.
    View in: PubMed
    Score: 0.016
  8. The transcriptional landscape of Shh medulloblastoma. Nat Commun. 2021 03 19; 12(1):1749.
    View in: PubMed
    Score: 0.016
  9. Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion. PLoS One. 2020; 15(12):e0243272.
    View in: PubMed
    Score: 0.016
  10. Artificial intelligence for automatic cerebral ventricle segmentation and volume calculation: a clinical tool for the evaluation of pediatric hydrocephalus. J Neurosurg Pediatr. 2021 02 01; 27(2):131-138.
    View in: PubMed
    Score: 0.016
  11. Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma. Acta Neuropathol Commun. 2020 10 28; 8(1):173.
    View in: PubMed
    Score: 0.016
  12. Deep Learning for Pediatric Posterior Fossa Tumor Detection and Classification: A Multi-Institutional Study. AJNR Am J Neuroradiol. 2020 09; 41(9):1718-1725.
    View in: PubMed
    Score: 0.015
  13. Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup. J Mol Diagn. 2020 07; 22(7):957-966.
    View in: PubMed
    Score: 0.015
  14. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples. J Neuropathol Exp Neurol. 2020 04 01; 79(4):437-447.
    View in: PubMed
    Score: 0.015
  15. Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience. J Neurooncol. 2019 Oct; 145(1):107-114.
    View in: PubMed
    Score: 0.014
  16. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors. Acta Neuropathol Commun. 2018 12 04; 6(1):134.
    View in: PubMed
    Score: 0.014
  17. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology. 2018 Oct; 38(5):475-483.
    View in: PubMed
    Score: 0.013
  18. Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma. J Neuropathol Exp Neurol. 2018 08 01; 77(8):696-702.
    View in: PubMed
    Score: 0.013
  19. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathol. 2018 08; 136(2):227-237.
    View in: PubMed
    Score: 0.013
  20. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol. 2018 06; 19(6):785-798.
    View in: PubMed
    Score: 0.013
  21. DNA methylation-based classification of central nervous system tumours. Nature. 2018 03 22; 555(7697):469-474.
    View in: PubMed
    Score: 0.013
  22. Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas. Nat Commun. 2017 08 04; 8(1):186.
    View in: PubMed
    Score: 0.012
  23. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin. Cancer Cell. 2015 Dec 14; 28(6):715-729.
    View in: PubMed
    Score: 0.011
  24. EAG2 potassium channel with evolutionarily conserved function as a brain tumor target. Nat Neurosci. 2015 Sep; 18(9):1236-46.
    View in: PubMed
    Score: 0.011
  25. Executive function in paediatric medulloblastoma: The role of cerebrocerebellar connections. J Neuropsychol. 2017 06; 11(2):174-200.
    View in: PubMed
    Score: 0.011
  26. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell. 2015 May 11; 27(5):728-43.
    View in: PubMed
    Score: 0.011
  27. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma. Acta Neuropathol Commun. 2014 Dec 24; 2:174.
    View in: PubMed
    Score: 0.010
  28. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathol. 2014 Jul; 128(1):137-49.
    View in: PubMed
    Score: 0.010
  29. The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States. Cancer. 2014 Jun 15; 120(12):1830-7.
    View in: PubMed
    Score: 0.010
  30. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell. 2014 Mar 17; 25(3):393-405.
    View in: PubMed
    Score: 0.010
  31. Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol. 2014 Mar 20; 32(9):886-96.
    View in: PubMed
    Score: 0.010
  32. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol. 2013 Aug 10; 31(23):2927-35.
    View in: PubMed
    Score: 0.009
  33. Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma. Childs Nerv Syst. 2013 Aug; 29(8):1253-62.
    View in: PubMed
    Score: 0.009
  34. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol. 2013 Mar; 125(3):359-71.
    View in: PubMed
    Score: 0.009
  35. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 2012 Apr; 123(4):473-84.
    View in: PubMed
    Score: 0.009
  36. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol. 2012 Apr; 123(4):529-38.
    View in: PubMed
    Score: 0.008
  37. Rapid diagnosis of medulloblastoma molecular subgroups. Clin Cancer Res. 2011 Apr 01; 17(7):1883-94.
    View in: PubMed
    Score: 0.008
  38. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol. 2010 Dec 10; 28(35):5188-96.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.